FHB:NASDAQFirst Hawaiian, Inc. Analysis
Data as of 2026-04-03 - not real-time
$25.05
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
First Hawaiian, Inc. trades at a trailing P/E of 11.4, well below the industry average of 16.6, and its DCF‑derived fair value of roughly $60 suggests a substantial valuation gap. The stock also offers an attractive 4.16% dividend yield with a payout ratio under 50%, indicating dividend sustainability. Recent leadership changes in the wealth‑management division—namely the retirement of the Vice Chairman—are being managed as a routine transition and have not materially impacted earnings, which grew 15.5% year‑over‑year. Technicals show the price hovering near the $25.16 resistance while respecting a solid $23.26 support, and a bullish MACD histogram (+0.19) hints at short‑term upward momentum. Volume is on an increasing trend, and the beta of 0.83 points to slightly lower volatility than the broader market, though the 30‑day volatility of ~26% remains elevated.
Overall, the combination of deep undervaluation, a strong dividend, solid profitability metrics (ROE ~10%) and manageable risk factors supports a positive outlook. However, the “underperform” consensus among analysts and the neutral trend direction temper enthusiasm, suggesting a cautious but optimistic positioning for investors.
Overall, the combination of deep undervaluation, a strong dividend, solid profitability metrics (ROE ~10%) and manageable risk factors supports a positive outlook. However, the “underperform” consensus among analysts and the neutral trend direction temper enthusiasm, suggesting a cautious but optimistic positioning for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bullish MACD
- High dividend yield provides downside cushion
- Increasing volume supports short‑term stability
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Sustainable dividend and low payout ratio
- Consistent earnings growth and solid ROE
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Deep undervaluation relative to peers
- Strong cash position and minimal debt
- Stable dividend stream and favorable long‑term fundamentals
Key Metrics & Analysis
Financial Health
Revenue Growth15.50%
Profit Margin32.37%
P/E Ratio11.4
ROE10.26%
ROA1.16%
P/B Ratio1.1
Op. Cash Flow$335.1M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI55.4
Support$23.26
Resistance$25.16
MA 20$24.23
MA 50$25.49
MA 200$25.22
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$60.54
Target Price$27.50
Upside/Downside9.78%
GradeUndervalued
TypeValue
Dividend Yield4.16%
Risk Assessment
Beta0.83
Volatility26.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.